Bile Acids: Key Players in Inflammatory Bowel Diseases? DOI Creative Commons
Aïcha Kriaa, Vincent Mariaule,

Amin Jablaoui

et al.

Cells, Journal Year: 2022, Volume and Issue: 11(5), P. 901 - 901

Published: March 5, 2022

Inflammatory bowel diseases (IBDs) have emerged as a public health problem worldwide with limited number of efficient therapeutic options despite advances in medical therapy. Although changes the gut microbiota composition are recognized key drivers dysregulated intestinal immunity, alterations bile acids (BAs) been shown to influence homeostasis and contribute pathogenesis disease. In this review, we explore interactions involving BAs IBDs, discuss how microbiota–BA–host axis may digestive inflammation.

Language: Английский

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis DOI Creative Commons
Juanjuan Wang, Ningning Zhu, Lei Su

et al.

Cells, Journal Year: 2023, Volume and Issue: 12(5), P. 793 - 793

Published: March 2, 2023

The gut microbiota, including bacteria, archaea, fungi, viruses and phages, inhabits the gastrointestinal tract. This commensal microbiota can contribute to regulation of host immune response homeostasis. Alterations have been found in many immune-related diseases. metabolites generated by specific microorganisms such as short-chain fatty acids (SCFAs), tryptophan (Trp) bile acid (BA) metabolites, not only affect genetic epigenetic but also impact metabolism cells, immunosuppressive inflammatory cells. cells (such tolerogenic macrophages (tMacs), dendritic (tDCs), myeloid-derived suppressive (MDSCs), regulatory T (Tregs), B (Breg) innate lymphocytes (ILCs)) Macs (iMacs), DCs, CD4 helper (Th)1, CD4Th2, Th17, natural killer (NK) NK neutrophils) express different receptors for SCFAs, Trp BA from microorganisms. Activation these promotes differentiation function inhibits causing reprogramming local systemic system maintain homeostasis individuals. We here will summarize recent advances understanding effects on homeostasis, especially functions

Language: Английский

Citations

199

Bile acids and their receptors in metabolic disorders DOI
Stefano Fiorucci,

Eleonora Distrutti,

Adriana Carino

et al.

Progress in Lipid Research, Journal Year: 2021, Volume and Issue: 82, P. 101094 - 101094

Published: Feb. 23, 2021

Language: Английский

Citations

175

Bile acids as modulators of gut microbiota composition and function DOI Creative Commons

Anaïs Larabi,

Hugo L. P. Masson, Andreas J. Bäumler

et al.

Gut Microbes, Journal Year: 2023, Volume and Issue: 15(1)

Published: Feb. 5, 2023

Changes in the composition of gut-associated microbial communities are associated with many human illnesses, but factors driving dysbiosis remain incompletely understood. One factor governing microbiota gut is bile. Bile acids shape through their antimicrobial activity and by activating host signaling pathways that maintain homeostasis. Although bile host-derived, functions integrally linked to bacterial metabolism, which shapes intestinal acid pool. Conditions change size or pool can trigger alterations exacerbate inflammation favor infection opportunistic pathogens. Therefore, manipulating might be a promising strategy remediate dysbiosis.

Language: Английский

Citations

143

Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism DOI

Sijing Dong,

Min Zhu, Ke Wang

et al.

Pharmacological Research, Journal Year: 2021, Volume and Issue: 171, P. 105767 - 105767

Published: July 14, 2021

Language: Английский

Citations

135

The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease DOI Creative Commons

John P. Thomas,

Dezső Módos,

Simon Rushbrook

et al.

Frontiers in Immunology, Journal Year: 2022, Volume and Issue: 13

Published: Feb. 3, 2022

Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammatory disorder of the gastrointestinal tract that arises due to complex interactions between host genetic risk factors, environmental and dysbiotic gut microbiota. Although metagenomic approaches have attempted characterise dysbiosis occurring in IBD, precise mechanistic pathways interlinking microbiota intestinal mucosa are still yet be unravelled. To deconvolute these interactions, more reductionist approach involving microbial metabolites has been suggested. Bile acids emerged as key class microbiota-associated perturbed IBD patients. In recent years, metabolomics studies revealed consistent defect bile acid metabolism with an increase primary reduction secondary This review explores evolving evidence specific interact epithelial immune cells contribute milieu seen IBD. Furthermore, we summarise linking intracellular known relevant including autophagy, apoptosis, inflammasome pathway. Finally, discuss how novel experimental bioinformatics could further advance our understanding role inform therapeutic strategies

Language: Английский

Citations

104

The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases DOI Creative Commons

Kelly Fogelson,

Pieter C. Dorrestein, Amir Zarrinpar

et al.

Gastroenterology, Journal Year: 2023, Volume and Issue: 164(7), P. 1069 - 1085

Published: Feb. 24, 2023

The human gut microbiome has been linked to numerous digestive disorders, but its metabolic products have much less well characterized, in part due the expense of untargeted metabolomics and lack ability process data. In this review, we focused on rapidly expanding information about bile acid repertoire produced by microbiome, including impacts acids a wide range host physiological processes diseases, discussed role short-chain fatty other important microbiome-derived metabolites. Of particular note is action metabolites throughout body, which impact ranging from obesity aging disorders traditionally thought as diseases nervous system, that are now recognized being strongly influenced it produces. We also highlighted emerging for modifying improve health or treat disease, "engineered native bacteria'' approach takes bacterial strains patient, modifies them alter metabolism, reintroduces them. Taken together, study derived provided insights into pathophysiological processes, substantial potential new approaches diagnostics therapeutics disease of, involving, gastrointestinal tract.

Language: Английский

Citations

72

Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation DOI
Rongrong Wu, Rui Xiong,

Yan Li

et al.

Journal of Autoimmunity, Journal Year: 2023, Volume and Issue: 141, P. 103062 - 103062

Published: May 27, 2023

Language: Английский

Citations

69

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity DOI Creative Commons
Lei Su,

Yunhuan Gao,

Rongcun Yang

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: May 15, 2023

Bile acids (BAs) as cholesterol-derived molecules play an essential role in some physiological processes such nutrient absorption, glucose homeostasis and regulation of energy expenditure. They are synthesized the liver primary BAs cholic acid (CA), chenodeoxycholic (CDCA) conjugated forms. A variety secondary deoxycholic (DCA) lithocholic (LCA) their derivatives is intestine through involvement various microorganisms. In addition to functions, metabolites also involved differentiation functions innate adaptive immune cells macrophages (Macs), dendritic (DCs), myeloid derived suppressive (MDSCs), regulatory T (Treg), Breg cells, helper (Th)17 CD4 Th1 Th2 CD8 B NKT cells. Dysregulation affects development diseases inflammatory bowel diseases. We here summarize recent advances how maintain gut systemic homeostasis, including metabolism derivatives, function effects on immune-associated disorders.

Language: Английский

Citations

50

Rattan Pepper Polysaccharide Regulates DSS-Induced Intestinal Inflammation and Depressive Behavior through Microbiota–Gut–Brain Axis DOI

Lili Chang,

Chendi Wang, Jing Peng

et al.

Journal of Agricultural and Food Chemistry, Journal Year: 2024, Volume and Issue: 72(1), P. 437 - 448

Published: Jan. 2, 2024

Inflammatory bowel disease (IBD) is a chronic and recurrent disease. Increasing evidence suggests higher incidence of depression in IBD patients compared with the general population, but underlying mechanism remains uncertain. Rattan pepper polysaccharide (RPP) an important active ingredient rattan pepper, yet its effects mechanisms on intestinal inflammation depression-like behavior remain largely unknown. This study aims to investigate ameliorating effect RPP dextran sulfate sodium salt (DSS)-induced as well reveal mechanism. Our results indicate that effectively ameliorated microbiota imbalance metabolic disorders short-chain fatty acids (SCFAs) bile mice DSS-induced inflammation, contributing recovery Th17/Treg homeostasis. Importantly, alleviated brain caused by inflammatory factors entering through blood–brain barrier. may be attributed inhibition TLR4/NF-κB signaling pathway, which alleviates neuroinflammation, activation CREB/BDNF improves synaptic dysfunction. Therefore, our findings suggest play role alleviating gut microbiota–gut–brain axis.

Language: Английский

Citations

16

Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease DOI Creative Commons

Salma Sultan,

Mohammed El‐Mowafy, Abdelaziz Elgaml

et al.

Frontiers in Physiology, Journal Year: 2021, Volume and Issue: 12

Published: Sept. 27, 2021

Inflammatory bowel diseases (IBD) are chronic medical disorders characterized by recurrent gastrointestinal inflammation. While the etiology of IBD is still unknown, pathogenesis disease results from perturbations in both gut microbiota and host immune system. Gut dysbiosis depleted diversity, reduced abundance short chain fatty acids (SCFAs) producers enriched proinflammatory microbes such as adherent/invasive E. coli H2S producers. This may contribute to inflammation through affecting either system or a metabolic pathway. The responses extensively discussed. In this review, we highlight main pathways that regulate host-microbiota interaction. We also discuss reported findings indicating microbial during has potential impact on colonocytes underlie progression. Moreover, present defectiveness adds symbiont will raise possibility associated with functional interactions, consequently modulates development. Finally, shed light possible therapeutic approaches targeting microbiome.

Language: Английский

Citations

88